DOCSLIB.ORG

SQSTM1 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
SQSTM1 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis ORIGINAL CONTRIBUTION SQSTM1 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis Faisal Fecto, MD; Jianhua Yan, MD, PhD; S. Pavan Vemula; Erdong Liu, MD; Yi Yang, MS; Wenjie Chen, MD; Jian Guo Zheng, MD; Yong Shi, MD, PhD; Nailah Siddique, RN, MSN; Hasan Arrat, MD; Sandra Donkervoort, MS; Senda Ajroud-Driss, MD; Robert L. Sufit, MD; Scott L. Heller, MD; Han-Xiang Deng, MD, PhD; Teepu Siddique, MD Background: The SQSTM1 gene encodes p62, a major In silico analysis of variants was performed to predict al- pathologic protein involved in neurodegeneration. terations in p62 structure and function. Objective: To examine whether SQSTM1 mutations con- Results: We identified 10 novel SQSTM1 mutations (9 tribute to familial and sporadic amyotrophic lateral scle- heterozygous missense and 1 deletion) in 15 patients (6 rosis (ALS). with familial ALS and 9 with sporadic ALS). Predictive in silico analysis classified 8 of 9 missense variants as Design: Case-control study. pathogenic. Setting: Academic research. Conclusions: Using candidate gene identification based on prior biological knowledge and the functional pre- Patients: A cohort of 546 patients with familial diction of rare variants, we identified several novel (n=340) or sporadic (n=206) ALS seen at a major aca- SQSTM1 mutations in patients with ALS. Our findings demic referral center were screened for SQSTM1 muta- provide evidence of a direct genetic role for p62 in ALS tions. pathogenesis and suggest that regulation of protein deg- radation pathways may represent an important thera- Main Outcome Measures: We evaluated the distri- peutic target in motor neuron degeneration. bution of missense, deletion, silent, and intronic vari- ants in SQSTM1 among our cohort of patients with ALS. Arch Neurol. 2011;68(11):1440-1446 MYOTROPHIC LATERAL SCLE- (also known as sequestosome 1). Ini- rosis (ALS) is a fatal para- tially, p62 was identified as a novel ubiq- lytic disorder caused by uitin-binding protein that acts as a phos- degeneration of motor photyrosine-independent ligand of the neurons in the brain and p56lck Src homology 2 (SH2) do- Author Affiliations: Division of spinal cord. About 90% of ALS is spo- main.10,11 Subsequently, p62 has been Neuromuscular Medicine, Ken A radic (SALS) with unknown cause. Famil- shown to have an important dual role in and Ruth Davee Department of 12 Neurology and Clinical ial ALS (FALS) is genetically heteroge- protein degradation via the proteasome Neurological Sciences neous and represents approximately 5% and as a link between protein aggrega- 13 (Drs Fecto, Yan, Liu, Chen, to 10% of ALS cases. The penetrance of ge- tion and autophagy via its interaction Zheng, Shi, Arrat, Ajroud-Driss, netic mutation–linked FALS may vary sub- with LC3/Atg8.14 Dysfunction in these Sufit, Heller, Deng, and stantially, ranging from classic mende- pathways has been implicated in various T. Siddique and Messrs Vemula lian pattern to apparently sporadic disease. forms of neurodegeneration. For ex- and Yang and Mss N. Siddique Mutations in the copper-zinc superoxide ample, p62 is present in neuronal and glial and Donkervoort) and dismutase gene (SOD1) account for ap- ubiquitin-positive inclusions of Alzhei- Department of Cell and proximately 20% of FALS cases and 1% of mer disease, Pick disease, dementia with Molecular Biology SALS cases and represent the most preva- Lewy bodies, Parkinson disease, and mul- (Dr T. Siddique), Feinberg 1,2 15,16 School of Medicine, and lent known cause of ALS. Several other tiple system atrophy. More recently, Interdepartmental Neuroscience genes, including TARDBP, FUS, OPTN, and p62 was shown to aggregate in patients 3-9 Program (Drs Fecto and VCP, have recently been linked to ALS. with ALS and in the G93A SOD1 mouse T. Siddique), Northwestern The SQSTM1 (OMIM 601530) gene en- model of FALS.17,18 Overexpression of p62 University, Chicago, Illinois. codes the ubiquitin-binding protein p62 with mutant SOD1 in NSC34 cells en- ARCH NEUROL / VOL 68 (NO. 11), NOV 2011 WWW.ARCHNEUROL.COM 1440 ©2011 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 09/29/2021 Table 1. SQSTM1 Variants in Patients With Familial Amyotrophic Lateral Sclerosis (FALS) and in Patients With Sporadic Amyotrophic Lateral Sclerosis (SALS) Patients Patients Patients With SALS Control Exon Change, bp Variant With FALS With SALS or FALS Subjects 1 c.98CϾT A33V 1/340 2/206 3/546 0/724 1 g.3Јϩ7GϾC Intronic 1/340 0/206 1/546 0/724 3 c.457GϾA V153I 0/340 2/206 2/546 0/724 4 g.5Ј − 37CϾT Intronic 1/340 2/206 3/546 0/738 5 c.683CϾT P228L 0/340 1/206 1/546 0/724 5 c.702GϾA V234V 1/340 0/206 1/546 0/724 5 c.714-716delGAA K238del 0/340 1/206 1/546 0/724 6 c.783CϾT H261H 0/340 1/206 1/546 0/738 6 c.952TϾC S318P 1/340 0/206 1/546 0/738 6 c.961CϾT R321C 0/340 1/206 1/546 0/738 7 c.1108TϾC S370P 1/340 0/206 1/546 0/733 8 c.1175CϾT P392L 2/340 1/206 3/546 0/737 8 c.1231GϾA G411S 1/340 0/206 1/546 0/737 8 c.1273GϾA G425R 0/340 1/206 1/546 0/737 Abbreviation: bp, base pair. hances aggregate formation, and this effect is signifi- supported probable ALS.24 All the ALS cases were negative cantly diminished when the ubiquitin-associated (UBA) for mutations in the SOD1, TARDBP, and FUS genes. By self- domain (UBA) of p62 is deleted.17 Mutant SOD1 can be reported race/ethnicity, 93.9% of the patients with ALS were recognized by p62 in a ubiquitin-independent fashion and white (European American), 2.5% Asian, 1.9% African targeted for autophagy.19 Furthermore, p62 colocalizes American, and 1.3% Latino. The race/ethnicity of 2 patients was unknown. By self-report, 97.6% of controls were white, with TDP-43 in brains of patients having frontotempo- 1.0% Latino, 0.8% Asian, and 0.6% African American. ral lobe degeneration with motor neuron disease.20 It was recently shown that p62 colocalizes with FUS and TDP-43 in ubiquitinated inclusions among motor neurons in spi- SEQUENCING ANALYSIS OF SQSTM1 nal cords from patients with SALS, non-SOD1 FALS, and ALS with dementia.21 In addition, overexpression of p62 Genomic DNA was extracted from transformed lymphoblas- reduces TDP-43 aggregation in an autophagy- and pro- toid cell lines or whole blood using standard protocols (Qia- 22 gen, Valencia, California). Intronic primers covering the teasome-dependent manner. Also, p62 knockout mice coding sequence were designed at least 50 base pairs away develop memory loss after neurodegeneration caused by from the intron and exon boundaries. Primers were designed accumulation of hyperphosphorylated tau and neurofi- using several products (Oligo Analyzer [IDT, Coralville, brillary tangles.23 Although some proteins may partici- Iowa], ExonPrimer [Institute of Human Genetics, Cologne, pate in pathogenic aggregates in a wide variety of neu- Germany], and UCSC Genome Browser [Center for Biomo- rodegenerative disorders, recent investigations indicate lecular Science & Engineering, Santa Cruz, California]). that they cause very specific disease phenotypes when Genomic DNA was amplified according to standard proto- mutant. Choosing candidate genes based on prior bio- cols. Unconsumed deoxyribonucleotide triphosphates and logical knowledge can identify causative genes for neu- primers were digested (ExoSAP-IT; USB, Cleveland, Ohio). rodegenerative disorders, including ALS. If present in ALS, Fluorescent dye–labeled single-strand DNA was amplified using sequencing reagents (GenomeLab DTCS Quick Start SQSTM1 mutations may have an increased aggregation Kit; Beckman Coulter, Fullerton, California), followed by potential. To investigate the role of p62 in ALS, we single-pass bidirectional sequencing (CEQ 8000 Genetic screened a large cohort of patients with ALS for SQSTM1 Analysis System, Beckman Coulter). Forward primer was mutations. used for mutation screening, and all variations were con- firmed by reverse sequencing. When a variant was identified, METHODS it was first excluded in the dbSNP Short Genetic Variations (http://www.ncbi.nlm.nih.gov/snp) and 1000 Genomes Proj- ect25 databases, and then more than 724 normal control DNA PARTICIPANTS samples (Table 1) were analyzed to exclude the possibility of a common polymorphism. A cohort of 340 patients with FALS, 206 patients with SALS, and 738 neurologically healthy control subjects was ascer- tained from our neurological diseases registry, in which par- BIOINFORMATICS ticipants are enrolled after informed consent is obtained. Pedigrees and clinical data were collected according to pro- An Internet server (NetPhos 2.0 [http://www.cbs.dtu.dk/services tocols approved by our institutional review board and met /NetPhos/]) was used to predict changes in phosphorylation Health Insurance Portability and Accountability Act stan- sites among variants identified during sequencing.26 Variants dards of confidentiality and disclosure. All the patients were were also analyzed using programs (SIFT27 and PMUT28)topre- diagnosed by board-certified neurologists and met the dict the effect of the mutations on p62. Three-dimensional mod- revised El Escorial World Federation of Neurology criteria eling was performed (Swiss-PdbViewer29) using 1Q02A back- for diagnosis of clinically definite, probable, or laboratory- bone as a template. ARCH NEUROL / VOL 68 (NO. 11), NOV 2011 WWW.ARCHNEUROL.COM 1441 ©2011 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 09/29/2021 A 1 2 3 4 5 6 7 8 B K238del R321C G411S A33V V153I P228L S318P S370P P392L G425R SH2 AID ZZ TRAF6 PEST PEST UBA C A33V V153I P228L
Load more

Recommended publications
  • Mtor: a Pharmacologic Target for Autophagy Regulation
    mTOR: a pharmacologic target for autophagy regulation Young Chul Kim, Kun-Liang Guan J Clin Invest. 2015;125(1):25-32. https://doi.org/10.1172/JCI73939. Review mTOR, a serine/threonine kinase, is a master regulator of cellular metabolism. mTOR regulates cell growth and proliferation in response to a wide range of cues, and its signaling pathway is deregulated in many human diseases. mTOR also plays a crucial role in regulating autophagy. This Review provides an overview of the mTOR signaling pathway, the mechanisms of mTOR in autophagy regulation, and the clinical implications of mTOR inhibitors in disease treatment. Find the latest version: https://jci.me/73939/pdf The Journal of Clinical Investigation REVIEW SERIES: AUTOPHAGY Series Editor: Guido Kroemer mTOR: a pharmacologic target for autophagy regulation Young Chul Kim and Kun-Liang Guan Department of Pharmacology and Moores Cancer Center, UCSD, La Jolla, California, USA. mTOR, a serine/threonine kinase, is a master regulator of cellular metabolism. mTOR regulates cell growth and proliferation in response to a wide range of cues, and its signaling pathway is deregulated in many human diseases. mTOR also plays a crucial role in regulating autophagy. This Review provides an overview of the mTOR signaling pathway, the mechanisms of mTOR in autophagy regulation, and the clinical implications of mTOR inhibitors in disease treatment. Overview of mTOR signaling pathway such as insulin and IGF activate their cognate receptors (recep- Nutrients, growth factors, and cellular energy levels are key deter- tor tyrosine kinases [RTKs]) and subsequently activate the PI3K/ minants of cell growth and proliferation. mTOR, a serine/threon- AKT signaling axis.
    [Show full text]
  • NF-B in Hematological Malignancies
    biomedicines Review NF-κB in Hematological Malignancies Véronique Imbert * and Jean-François Peyron Centre Méditerranéen de Médecine Moléculaire, INSERM U1065, Université Côte d’Azur, 06204 Nice, France; [email protected] * Correspondence: [email protected]; Tel.: +33-489-064-315 Academic Editor: Véronique Baud Received: 28 April 2017; Accepted: 26 May 2017; Published: 31 May 2017 Abstract: NF-κB (Nuclear Factor K-light-chain-enhancer of activated B cells) transcription factors are critical regulators of immunity, stress response, apoptosis, and differentiation. Molecular defects promoting the constitutive activation of canonical and non-canonical NF-κB signaling pathways contribute to many diseases, including cancer, diabetes, chronic inflammation, and autoimmunity. In the present review, we focus our attention on the mechanisms of NF-κB deregulation in hematological malignancies. Key positive regulators of NF-κB signaling can act as oncogenes that are often prone to chromosomal translocation, amplifications, or activating mutations. Negative regulators of NF-κB have tumor suppressor functions, and are frequently inactivated either by genomic deletions or point mutations. NF-κB activation in tumoral cells is also driven by the microenvironment or chronic signaling that does not rely on genetic alterations. Keywords: NF-κB; leukemia; lymphoma 1. Introduction The NF-κB family of transcription factors coordinates inflammatory responses, innate and adaptive immunity, cellular differentiation, proliferation, and survival in all multicellular organisms. The NF-κB system is tightly controlled at various levels, and deregulations of NF-κB homeostasis have been implicated in a wide range of diseases, ranging from inflammatory and immune disorders to cancer [1,2]. In particular, NF-κB is a key link between chronic inflammation and cancer transformation [3].
    [Show full text]
  • Archives of Agriculture and Environmental Science
    ISSN (Online) : 2456-6632 Archives of Agriculture and Environmental Science An International Journal Volume 4 | Issue 2 Agriculture and Environmental Science Academy www.aesacademy.org Scan to view it on the web Archives of Agriculture and Environmental Science (Abbreviation: Arch. Agr. Environ. Sci.) ISSN: 2456-6632 (Online) An International Research Journal of Agriculture and Environmental Sciences Volume 4 Number 2 2019 Abstracted/Indexed: The journal AAES is proud to be a registered member of the following leading abstracting/indexing agencies: Google Scholar, AGRIS-FAO, CrossRef, Informatics, jGate @ e-Shodh Sindhu, WorldCat Library, OpenAIRE, Zenodo ResearchShare, DataCite, Index Copernicus International, Root Indexing, Research Gate etc. All Rights Reserved © 2016-2019 Agriculture and Environmental Science Academy Disclaimer: No part of this booklet may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without written permission of the publisher. However, all the articles published in this issue are open access articles which are distributed under the terms of the Creative Commons Attribution 4.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited For information regarding permission, write us [email protected]. An official publication of Agriculture and Environmental Science Academy 86, Gurubaksh Vihar (East) Kankhal Haridwar-249408 (Uttarakhand), India Website: https://www.aesacademy.org Email: [email protected] Phone: +91-98971-89197 Archives of Agriculture and Environmental Science (An International Research Journal) (Abbreviation: Arch. Agri. Environ. Sci.) Aims & Objectives: The journal is an official publication of Agriculture and Environmental Science Academy.
    [Show full text]
  • Strategies for Non-Invasive Management of High-Grade Cervical Intraepithelial Neoplasia
    Strategies for non-invasive management of high-grade cervical intraepithelial neoplasia Citation for published version (APA): Koeneman, M. M. (2019). Strategies for non-invasive management of high-grade cervical intraepithelial neoplasia: prognostic biomarkers and immunotherapy. Maastricht University. https://doi.org/10.26481/dis.20190116mk Document status and date: Published: 01/01/2019 DOI: 10.26481/dis.20190116mk Document Version: Publisher's PDF, also known as Version of record Please check the document version of this publication: • A submitted manuscript is the version of the article upon submission and before peer-review. There can be important differences between the submitted version and the official published version of record. People interested in the research are advised to contact the author for the final version of the publication, or visit the DOI to the publisher's website. • The final author version and the galley proof are versions of the publication after peer review. • The final published version features the final layout of the paper including the volume, issue and page numbers. Link to publication General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal.
    [Show full text]
  • Hydroxyurea Scavenges Free Radicals and Induces the Expression of Antioxidant Genes in Human Cell Cultures Treated with Hemin
    ORIGINAL RESEARCH published: 17 July 2020 doi: 10.3389/fimmu.2020.01488 Hydroxyurea Scavenges Free Radicals and Induces the Expression of Antioxidant Genes in Human Cell Cultures Treated With Hemin Sânzio Silva Santana 1,2, Thassila Nogueira Pitanga 1,2, Jeanne Machado de Santana 1, Dalila Lucíola Zanette 1, Jamile de Jesus Vieira 1, Sètondji Cocou Modeste Alexandre Yahouédéhou 1, Corynne Stéphanie Ahouefa Adanho 1, Sayonara de Melo Viana 1, Nivea Farias Luz 1, Valeria Matos Borges 1 and Marilda Souza Goncalves 1,3* 1 Instituto Gonçalo Moniz, Fundação Oswaldo Cruz (IGM/FIOCRUZ-BA), Salvador, Brazil, 2 Faculdade de Biomedicina, Universidade Católica do Salvador (UCSal), Salvador, Brazil, 3 Faculdade de Farmácia, Universidade Federal da Bahia (UFBA), Salvador, Brazil Edited by: The excessive release of heme during hemolysis contributes to the severity of sickle Caroline Le Van Kim, cell anemia (SCA) by exacerbating hemoglobin S (HbS) autoxidation, inflammation and Université Paris Diderot, France systemic tissue damage. The present study investigated the effect of hydroxyurea Reviewed by: Nicola Conran, (HU) on free radical neutralization and its stimulation of antioxidant genes in human Campinas State University, Brazil peripheral blood mononuclear cells (PBMC) and human umbilical vein endothelial cells Marc Romana, INSERM U1134 Biologie Intégrée du (HUVEC) in the presence or absence of hemin. HU (100 and 200 µM) significantly Globule Rouge, France reduced the production of intracellular reactive oxygen species (ROS) induced by hemin *Correspondence: at 70 µM in HUVEC. HUVECs treated with HU+hemin presented significant increases Marilda Souza Goncalves in nitric oxide (NO) production in culture supernatants. HU alone or in combination mari@bahia.fiocruz.br with hemin promoted the induction of superoxide dismutase-1 (SOD1) and glutathione Specialty section: disulfide-reductase (GSR) in HUVECs and PBMCs, and glutathione peroxidase (GPX1) This article was submitted to in PBMCs.
    [Show full text]
  • Software in the Scientific Literature: Problems with Seeing, Finding, And
    Software in the Scientific Literature: Problems with Seeing, Finding, and Using Software Mentioned in the Biology Literature James Howison School of Information, University of Texas at Austin, 1616 Guadalupe Street, Austin, TX 78701, USA. E-mail: [email protected] Julia Bullard School of Information, University of Texas at Austin, 1616 Guadalupe Street, Austin, TX 78701, USA. E-mail: [email protected] Software is increasingly crucial to scholarship, yet the incorporates key scientific methods; increasingly, software visibility and usefulness of software in the scientific is also key to work in humanities and the arts, indeed to work record are in question. Just as with data, the visibility of with data of all kinds (Borgman, Wallis, & Mayernik, 2012). software in publications is related to incentives to share software in reusable ways, and so promote efficient Yet, the visibility of software in the scientific record is in science. In this article, we examine software in publica- question, leading to concerns, expressed in a series of tions through content analysis of a random sample of 90 National Science Foundation (NSF)- and National Institutes biology articles. We develop a coding scheme to identify of Health–funded workshops, about the extent that scientists software “mentions” and classify them according to can understand and build upon existing scholarship (e.g., their characteristics and ability to realize the functions of citations. Overall, we find diverse and problematic Katz et al., 2014; Stewart, Almes, & Wheeler, 2010). In practices: Only between 31% and 43% of mentions particular, the questionable visibility of software is linked to involve formal citations; informal mentions are very concerns that the software underlying science is of question- common, even in high impact factor journals and across able quality.
    [Show full text]
  • Molecular Insights Into an Ancient Form of Paget's Disease of Bone
    Molecular insights into an ancient form of Paget’s disease of bone Barry Shawa,1, Carla L. Burrellb,c,1, Darrell Greend,1, Ana Navarro-Martineza, Daniel Scotta, Anna Daroszewskae,f,g, Rob van ’t Hofe, Lynn Smithh, Frank Hargraveh, Sharad Mistryi, Andrew Bottrilli, Benedikt M. Kesslerj, Roman Fischerj, Archana Singhk, Tamas Dalmayk, William D. Fraserd,l, Kirstin Hennebergerm, Turi Kingn, Silvia Gonzalezb, and Robert Layfielda,2 aSchool of Life Sciences, University of Nottingham, NG7 2UH Nottingham, United Kingdom; bResearch Centre for Evolutionary Anthropology and Paleoecology, Liverpool John Moores University, L3 3AF Liverpool, United Kingdom; cFaculty of Archaeology, Leiden University, 2333 CC Leiden, The Netherlands; dNorwich Medical School, University of East Anglia, NR4 7TJ Norwich, United Kingdom; eInstitute of Ageing and Chronic Disease, University of Liverpool, L7 8TX Liverpool, United Kingdom; fDepartment of Clinical Biochemistry and Metabolic Medicine, Royal Liverpool and Broadgreen University Hospitals National Health Service Trust, L7 8XP Liverpool, United Kingdom; gDepartment of Rheumatology, Royal Liverpool and Broadgreen University Hospitals National Health Service Trust, L7 8XP Liverpool, United Kingdom; hNorton Priory Museum and Gardens, WA7 1SX Runcorn, United Kingdom; iProtein & Nucleic Acid Chemistry Laboratory, University of Leicester, LE1 9HN Leicester, United Kingdom; jTarget Discovery Institute, University of Oxford, OX3 7FZ Oxford, United Kingdom; kSchool of Biological Sciences, University of East Anglia, NR4 7TJ Norwich, United Kingdom; lDepartment of Clinical Biochemistry, Norfolk and Norwich University Hospital, NR4 7UY Norwich, United Kingdom; mInstitute for Biochemistry and Biology, University of Potsdam, 14476 Potsdam, Germany; and nDepartment of Genetics and Genome Biology, University of Leicester, LE1 7RH Leicester, United Kingdom Edited by G.
    [Show full text]
  • The Research Road We Make: Statistics for the Uninitiated
    The Research Road We Make: Statistics for the Uninitiated Saviour Formosa PhD Sandra Scicluna PhD Jacqueline Azzopardi PhD Janice Formosa Pace MSc Trevor Calafato MSc 2011 Published by the National Statistics Office, Malta Published by the National Statistics Office Lascaris Valletta VLT 2000 Malta Tel.: (+356) 25997000 Fax:(+356) 25997205 / 25997103 e-mail: [email protected] website: http://www.nso.gov.mt CIP Data The Research Road We Make: Statistics for the Uninitiated – Valletta: National Statistics Office, 2011 xxii, 279p. ISBN: 978-99957-29-14-1 For further information, please contact: Unit D2: External Cooperation and Communication Directorate D: Resources and Support Services National Statistics Office Lascaris Valletta VLT 2000 Malta Tel: (+356) 25997219 NSO publications are available from: Unit D2: External Cooperation and Communication Directorate D: Resources and Support Services National Statistics Office Lascaris Valletta VLT 2000 Malta Tel.: (+356) 25997219 Fax: (+356) 25997205 Contents Page Preface vii Foreword viii Acknowledgements ix Abbreviations xi Glossary xiii Imagery xix Introduction xxi Chapter 1 What is Statistics? An Intro for the Uninitiated! 1 Why Statistics? 3 The Tower of Babel Syndrome or Valhalla? 4 The ‘fear of stats’ 5 Myths and Realities 5 Chapter 2 Research Methodology 7 The Research Design 9 Social Scientific Research Methods 10 Research Problems 11 Sampling 11 Causality, Association and Correlations 12 Methods of Research 13 Chapter 3 DIKA 25 Why is Research Necessary? 29 Forms of Research 31 Types of Research
    [Show full text]
  • The Discovery and Evaluation of Inhibitors of the Keap1-Nrf2 Protein-Protein Interaction
    THE DISCOVERY AND EVALUATION OF INHIBITORS OF THE KEAP1-NRF2 PROTEIN-PROTEIN INTERACTION Rowena Melanie Hancock July 2012 A thesis submitted for the degree of Doctor of Philosophy of University College London Department of Pharmaceutical and Biological Chemistry UCL School of Pharmacy 1 Plagiarism Statement This thesis describes research conducted at University College London, School of Pharmacy between October 2008 and October 2011 under the supervision of Dr Geoff Wells. I certify that the research described is original and that any parts of the work that have been conducted by collaboration are clearly indicated. I also certify that I have written all the text herein and have clearly indicated by suitable citation any part of this dissertation that has already appeared in publication. Signature Date 2 Table of Contents Acknowledgements ............................................................................................................... 7 Abbreviations ......................................................................................................................... 8 Abstract ................................................................................................................................. 11 1. Introduction: Keap1-Nrf2 protein-protein interaction ................................................. 12 1.1 Cancer ........................................................................................................................ 12 1.2 The Hallmarks of cancer .........................................................................................
    [Show full text]
  • Assessment of the Impact of the Electronic Submission and Review Environment on the Efficiency and Effectiveness of the Review of Human Drugs – Final Report
    Evaluations and Studies of New Drug Review Programs Under PDUFA IV for the FDA Contract No. HHSF223201010017B Task No. 2 Assessment of the Impact of the Electronic Submission and Review Environment on the Efficiency and Effectiveness of the Review of Human Drugs – Final Report September 9, 2011 Booz | Allen | Hamilton Assessment of the Impact of the Electronic Submission and Review Environment Final Report Table of Contents EXECUTIVE SUMMARY .............................................................................................................. 1 Assessment Overview .......................................................................................................... 1 Degree of Electronic Implementation ................................................................................... 1 Baseline Review Performance ............................................................................................. 2 Exchange and Content Data Standards ............................................................................... 4 Review Tools and Training Analysis .................................................................................... 5 Current Organization and Responsibilities ........................................................................... 6 Progress against Ideal Electronic Review Environment ....................................................... 6 Recommendations ............................................................................................................... 8 ASSESSMENT OVERVIEW ........................................................................................................
    [Show full text]
  • Analyzing Data with Graphpad Prism
    Analyzing Data with GraphPad Prism A companion to GraphPad Prism version 3 Harvey Motulsky President GraphPad Software Inc. [email protected] GraphPad Software, Inc. © 1999 GraphPad Software, Inc. All rights reserved. All Rights Reserved. GraphPad Prism, Prism and InStat are registered trademarks of GraphPad Contents Software, Inc. GraphPad is a trademark of GraphPad Software, Inc. Use of the software is subject to the restrictions contained in the Preface.........................................................................................................2 accompanying software license agreement. Introduction to statistical comparisons..........................................................3 Garbage in, garbage out ...................................................................................3 Citation: H.J. Motulsky, Analyzing Data with GraphPad Prism, 1999, When do you need statistical calculations? ........................................................3 The key concept: Sampling from a population....................................................4 GraphPad Software Inc., San Diego CA, www.graphpad.com. Confidence intervals ........................................................................................8 P values ..........................................................................................................9 Hypothesis testing and statistical significance................................................... 11 Acknowledgements: The following individuals made substantial Statistical power ...........................................................................................
    [Show full text]
  • Sequestosome-1 (SQSTM1) Sequence Variants in ALS Cases in the UK: Prevalence and Coexistence of SQSTM1 Mutations in ALS Kindred with PDB
    European Journal of Human Genetics (2014) 22, 492–496 & 2014 Macmillan Publishers Limited All rights reserved 1018-4813/14 www.nature.com/ejhg ARTICLE Sequestosome-1 (SQSTM1) sequence variants in ALS cases in the UK: prevalence and coexistence of SQSTM1 mutations in ALS kindred with PDB Chun T Kwok1, Alex Morris1 and Jacqueline S de Belleroche*1 Mutations in the SQSTM1 gene have been reported to be associated with amyotrophic lateral sclerosis (ALS). We sought to determine the frequency of these mutations in a UK familial ALS (FALS) cohort. Sequences of all eight exons of the SQSTM1 gene were analysed in index cases from 61 different FALS kindred lacking known FALS mutations. Six exonic variants c.463G4A, p.(Glu155Lys), c.822G4C, p.(Glu274Asp), c.888G4T, p.( ¼ ), c.954C4T, p.( ¼ ), c.1038G4A, p.( ¼ ) and c.1175C4T, p.(Pro392Leu) were identified in five FALS index cases, three of which were non-synonymous and three were synonymous. One index case harboured three variants (c.822G4C, c.888G4T and c.954C4T), and a second index case harboured two variants (c.822G4C and c.954C4T). Only the p.(Pro392Leu) and p.(Glu155Lys) mutations were predicted to be pathogenic. In one p.(Pro392Leu) kindred, the carrier developed both ALS and Paget’s disease of bone (PDB), and, in the p.(Glu155Lys) kindred, the father of the proband developed PDB. All p.(Pro392Leu) carriers were heterozygous for a previously reported founder haplotype for PDB, where this mutation has an established causal effect. The frequency of the p.(Pro392Leu) mutation in this UK FALS cohort was 2.3% and 0.97% overall including three previously screened FALS cohorts.
    [Show full text]